In conclusion, our findings show that not p53 but PCNA appears to be useful in detecting malignant potential of these tumors.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The aim of this study is to examine expression of Proliferating cell nuclear antigen (PCNA) and p53 oncoprotein in gastric neuroendocrine tumors. 35 gastric neuroendocrine tumors were analyzed for first histopathologic features and then, immunohistochemical study was done to detect labeling index of PCNA and accumulation of p53 protein by using monoclonal antibodies and the Labeled strepavidin-biotin method.
📊
Key Findings & Data:PCNA labeling index and p53 protein expression were compared with histopatholoic features in statistical methods of Fisher's exact, chi square and logistic regression tests.
💡
Conclusion & Impact:In conclusion, our findings show that not p53 but PCNA appears to be useful in detecting malignant potential of these tumors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The aim of this study is to examine expression of Proliferating cell nuclear antigen (PCNA) and p53 oncoprotein in gastric neuroendocrine tumors. 35 gastric neuroendocrine tumors were analyzed for first histopathologic features and then, immunohistochemical study was done to detect labeling index of PCNA and accumulation of p53 protein by using monoclonal antibodies and the Labeled strepavidin-biotin method. PCNA labeling index and p53 protein expression were compared with histopatholoic features in statistical methods of Fisher's exact, chi square and logistic regression tests. No significant correlation was found between them except PCNA score and depth of invasion. In conclusion, our findings show that not p53 but PCNA appears to be useful in detecting malignant potential of these tumors.
🔖
Cite This Article
DOĞUSOY, G., GÖKSEL, S., GÖÇENER, S., DURAK, H., PAKİŞ, I., ERSOY, G. (2022). An immunohistohemical study of gastric neuroendocrine tumors: Expression of proliferating cell nuclear antigen and P53 oncoprotein. Turkish Journal of Medical Sciences, Cilt: 29 - Sayı: 6, 631–636. https://ajindex.com/articles/612476
Klöppel G., Heitz Pu., Capella C., Solcia E.: Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World, Surg 20: 132-141, 1996
Capella C, Heitz PU, Pöfler H, Solcia E, Klöppel G. Resived classification of neuroendocrine tumors of the lung, pancreas and gut. Digestion 55 (Suppl 3): 11-23, 1994
Rindi G.: Clinicopathologic aspects of gastric neuroendocrine tumors. Am J Surg Pathol 19 (Suppl 1): S20-S29, 1995
Rind iG., Bordi C., Rappel S., La Rosa., Stolte M., Solcia E.: Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 20: 168-172, 1996
Maeda K, Chung Y, Onoda N, Kato Y, Nitta A, Arimoto Y, Yamada N, Kondo Y, Sowa M. Proliferating cell nuclear antigen labeling index o f preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Cancer 73; 528-533, 1994
Wright PA, Quirke P, Attanoos R, Williams GT. Molecular pathology of gastric carcinoma: Progress and prospects. Hum Pathol 23: 848-859, 1992
Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM. The molecular biology of esophageal and gastric cancer and their precursors: Oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 25: 968-981, 1994
Hurlimann J, Saraga EP. Expression of p53 protein in gastric carcinomas. Association with histologic type and prognosis. Am J Pathol 18(12): 1247- 1253, 1994
Sasano H, Date F, Imatani A, Asaki S, Nagura H. Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells. Hum Pathol 24: 584- 589, 1993
Fukunaga M, Monden T, Nakanishi H, Ohue M, Fukuda K, Tomita N, Shimano T, Mori T. Immunohistochemical study of p53 in gastric carcinoma. Am J Clin Pathol 101: 177-180, 1994
Martin IG, Scott NS, Bell S, Pickles A, Murday V, Dixon MF, Johnston D, Quirke P. Gastric cancer is not associated with Ki ras mutations or abnormal p53 expression. Gut 31: A1178, 1990
Guesdon JL, Ternyn CKT, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic tecniques. J. Histochem. Cytochem. 27; 1131- 1139, 1979
Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 76: 720-726, 1995
Ooi A, Hayashi H, Katsuda S, Nakanishi I. Gastric carcinoma cells with endocrine differentiation show no evidence of poliferation. Hum Pathol 23: 736-741, 1992